PnuVax Incorporated

Canada

 
Quantité totale PI 10
Rang # Quantité totale PI 154 873
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 240 658
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 0
5 2
1 0
0
 
Dernier brevet 2024 - Glycated proteins
Premier brevet 2010 - High yield yellow fever virus st...
Dernière marque 2020 - CoVaximab
Première marque 2009 - Pnuvax

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Glycated proteins. Discloses herein are conjugates of a protein and one or more reducing sugars, ...
2020 P/S Antivirals
2014 Invention High yield yellow fever virus strain with increased propagation in cells. The invention provides ...
2010 Invention High yield yellow fever virus strain with increased propagation in cells. The invention pro...
2009 P/S Vaccines for the prevention of or antibodies for the treatment of diseases in humans caused by ha...